HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael P Manns Selected Research
Michael P Manns Research Topics
Disease
137
Infections
03/2023 - 01/2002
87
Neoplasms (Cancer)
01/2021 - 02/2002
70
Fibrosis (Cirrhosis)
01/2023 - 02/2002
67
Liver Diseases (Liver Disease)
01/2023 - 02/2002
59
Chronic Hepatitis C
02/2022 - 02/2002
52
Hepatitis C
03/2023 - 01/2002
51
Autoimmune Hepatitis
12/2022 - 01/2002
51
Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2002
45
Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 02/2002
28
Hepatitis
01/2021 - 02/2002
24
Hepatitis B
01/2022 - 02/2002
23
Inflammation (Inflammations)
11/2021 - 05/2002
23
Sclerosing Cholangitis
01/2021 - 06/2003
20
Virus Diseases (Viral Diseases)
01/2019 - 02/2002
18
Hepatitis D
01/2023 - 01/2002
18
End Stage Liver Disease
12/2020 - 02/2003
15
Liver Failure
01/2021 - 02/2002
15
Chronic Hepatitis B
01/2020 - 01/2002
14
Cholangiocarcinoma
01/2022 - 02/2002
14
Ascites
01/2022 - 04/2003
12
Disease Progression
01/2021 - 02/2002
12
Acute Liver Failure (Fulminant Hepatic Failure)
08/2020 - 10/2006
12
Chronic Hepatitis (Chronic Active Hepatitis)
01/2020 - 02/2004
11
Pathologic Constriction (Stenosis)
01/2020 - 10/2006
9
Hemorrhage
01/2021 - 04/2003
9
Liver Neoplasms (Liver Cancer)
01/2021 - 04/2014
9
Neoplasm Metastasis (Metastasis)
11/2019 - 02/2002
9
Reinfection
01/2016 - 02/2003
8
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2020 - 05/2002
7
Portal Hypertension
01/2022 - 07/2003
7
Non-alcoholic Fatty Liver Disease
01/2021 - 02/2012
7
Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2021 - 01/2002
7
Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2002
7
Insulin Resistance
01/2020 - 08/2004
7
Necrosis
11/2013 - 02/2007
6
Cholestasis
01/2019 - 05/2005
6
Pancreatic Neoplasms (Pancreatic Cancer)
12/2017 - 06/2003
6
Coinfection
05/2012 - 03/2007
6
Viremia
02/2012 - 07/2004
6
Gilbert Disease
07/2009 - 05/2005
5
Acute Kidney Injury (Acute Renal Failure)
01/2022 - 05/2012
5
Cholangitis
12/2021 - 05/2005
5
Persistent Infection
01/2017 - 02/2006
Drug/Important Bio-Agent (IBA)
57
Antiviral Agents (Antivirals)
IBA
02/2022 - 02/2002
50
Interferons
IBA
01/2022 - 01/2002
44
Ribavirin (Virazole)
FDA Link
Generic
01/2018 - 02/2002
34
RNA (Ribonucleic Acid)
IBA
01/2023 - 08/2002
29
Proteins (Proteins, Gene)
FDA Link
01/2022 - 02/2003
28
Antigens
IBA
01/2022 - 07/2004
27
Biomarkers (Surrogate Marker)
IBA
01/2021 - 07/2003
26
Interferon-alpha (Interferon Alfa)
IBA
01/2023 - 01/2002
21
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 01/2002
20
Hepatitis B Surface Antigens (HBsAg)
FDA Link
01/2021 - 03/2007
19
Bilirubin
IBA
12/2021 - 02/2002
18
Autoantibodies
IBA
01/2022 - 01/2002
17
Antibodies
IBA
01/2022 - 01/2002
16
Cytokines
IBA
10/2020 - 10/2002
14
Peptides (Polypeptides)
IBA
07/2021 - 09/2007
13
Messenger RNA (mRNA)
IBA
01/2021 - 02/2002
12
Telomerase (Telomerase Reverse Transcriptase)
IBA
12/2012 - 08/2004
11
Albumins
IBA
12/2021 - 01/2007
11
Protease Inhibitors (Protease Inhibitor)
IBA
01/2017 - 11/2006
10
Sofosbuvir
IBA
03/2023 - 05/2013
10
Immunoglobulins (Immunoglobulin)
IBA
12/2021 - 10/2006
10
Autoantigens
IBA
12/2019 - 11/2002
9
Hepatitis B e Antigens
IBA
01/2020 - 01/2002
9
Enzymes
IBA
01/2019 - 08/2002
9
Vaccines
IBA
01/2017 - 01/2003
9
N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamide
IBA
08/2014 - 02/2009
8
Budesonide (Pulmicort)
FDA Link
Generic
12/2021 - 10/2005
8
Azathioprine (Imuran)
FDA Link
Generic
12/2020 - 10/2010
8
Alanine Transaminase (SGPT)
IBA
02/2020 - 01/2002
8
Ligands
IBA
01/2019 - 11/2007
8
MicroRNAs (MicroRNA)
IBA
01/2019 - 07/2009
7
Immunoglobulin G (IgG)
IBA
04/2022 - 01/2006
7
Transaminases (Aminotransferases)
IBA
04/2022 - 02/2002
7
Steroids
IBA
12/2021 - 02/2004
7
Interleukin-6 (Interleukin 6)
IBA
04/2018 - 07/2003
7
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2016 - 01/2006
7
Lamivudine (Epivir)
FDA Link
05/2012 - 02/2002
7
hepatitis B hyperimmune globulin
IBA
03/2011 - 02/2002
6
Anti-Bacterial Agents (Antibiotics)
IBA
11/2021 - 07/2005
6
Glucose (Dextrose)
FDA Link
Generic
03/2021 - 07/2004
6
Bile Acids and Salts (Bile Acids)
IBA
12/2019 - 12/2003
6
peginterferon alfa-2b (Pegintron)
FDA Link
05/2014 - 09/2003
5
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2021 - 02/2011
5
peginterferon alfa-2a (Pegasys)
FDA Link
01/2020 - 04/2010
5
Irinotecan (Camptosar)
FDA Link
Generic
11/2019 - 05/2005
5
Acids
IBA
10/2019 - 08/2007
5
Insulin (Novolin)
FDA Link
01/2019 - 04/2003
5
Sorafenib (BAY 43-9006)
FDA Link
03/2018 - 04/2013
5
adefovir
IBA
07/2014 - 10/2004
Therapy/Procedure
152
Therapeutics
01/2022 - 01/2002
97
Liver Transplantation
01/2022 - 02/2002
27
Transplantation
01/2021 - 02/2003
15
Immunotherapy
01/2019 - 07/2004
12
Drug Therapy (Chemotherapy)
01/2019 - 11/2005
6
Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2022 - 05/2017
6
Drug Tapering
06/2015 - 05/2006
5
Organ Transplantation
09/2020 - 06/2003